The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Endocannabinoids and traumatic brain injury
Open accessAbstract
Traumatic brain injury (TBI) represents the leading cause of death in young individuals. It triggers the accumulation of harmful mediators, leading to secondary damage, yet protective mechanisms are also set in motion. The endocannabinoid (eCB) system consists of ligands, such as anandamide and 2‐arachidonoyl‐glycerol (2‐AG), receptors (e.g. CB1, CB2), transporters and enzymes, which are responsible for the ‘on‐demand’ synthesis and degradation of these lipid mediators. There is a large body of evidence showing that eCB are markedly increased in response to pathogenic events. This fact, as well as numerous studies on experimental models of brain toxicity, neuroinflammation and trauma supports the notion that the eCB are part of the brain's compensatory or repair mechanisms. These are mediated via CB receptors signalling pathways that are linked to neuronal survival and repair. The levels of 2‐AG, the most highly abundant eCB, are significantly elevated after TBI and when administered to TBI mice, 2‐AG decreases brain oedema, inflammation and infarct volume and improves clinical recovery. The role of CB1 in mediating these effects was demonstrated using selective antagonists or CB1 knockout mice. CB2 were shown in other models of brain insults to reduce white blood cell rolling and adhesion, to reduce infarct size and to improve motor function. This review is focused on the role the eCB system plays as a self‐neuroprotective mechanism and its potential as a basis for the development of novel therapeutic modality for the treatment of CNS pathologies with special emphasis on TBI. LINKED ARTICLES This article is part of a themed issue on Cannabinoids in Biology and Medicine. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2011.163.issue‐7
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Self-citation2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
Guide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947
The Role of Excitatory Amino Acids and NMDA Receptors in Traumatic Brain Injury
Faden, A. I., Demediuk, P., Panter, S. S., & Vink, R. (1989) · Science · doi:10.1126/science.2567056 · Cited by 1,508
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Mezey, É., Tóth, Z. E., Cortright, D. N., Arzubi, M. K., Krause, J. E., Elde, R., Guo, A., Blumberg, P. M., & Szallasi, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3655 · Cited by 850
Katona, I., Rancz, E. A., Acsády, L., Ledent, C., Mackie, K., Hájos, N., & Freund, T. F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09506.2001 · Cited by 668
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.
Pacher, P., & Haskó, G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707582 · Cited by 217
Research works printed but not linked: 80
- 10.1096/fj.05-3995fje · DOI · Paper page
- 10.1523/JNEUROSCI.3101-05.2006 · DOI · Paper page
- 10.1016/S0306-4522(00)00389-4 · DOI · Paper page
- Alessandri B, 1996, Application of glutamate in the cortex of rats: a microdialysis study, Acta Neurochir Suppl, 67, 6, 10.1007/978-3-7091-6894-3_2 · doi:10.1007/978-3-7091-6894-3_2
- 10.2174/157015907780866884 · DOI · Paper page
- 10.1089/neu.1999.16.1165 · DOI
- 10.1517/13543784.15.4.351 · DOI
- 10.1097/00005344-200036051-00104 · doi:10.1097/00005344-200036051-00104
- 10.2174/157015907780866910 · DOI
- 10.2119/2008-00050.Beauchamp · DOI · Paper page
- 10.1097/00004647-199703000-00004 · DOI
- 10.1096/fj.03-0323fje · DOI · Paper page
- 10.1523/JNEUROSCI.3923-04.2005 · DOI · Paper page
- 10.1038/sj.bjp.0707505 · DOI · Paper page
- 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R · DOI · Paper page
- 10.1006/bbrc.1999.0254 · DOI · Paper page
- 10.1089/neu.1998.15.253 · DOI
- 10.1189/jlb.0405216 · DOI · Paper page
- 10.1124/mol.65.4.999 · DOI · Paper page
- 10.1038/39807 · DOI · Paper page
- 10.1093/brain/awm160 · DOI · Paper page
- 10.1097/00004647-200101000-00002 · DOI · Paper page
- 10.1097/00004647-199902000-00003 · doi:10.1097/00004647-199902000-00003
- 10.1161/01.RES.87.4.323 · DOI
- 10.1161/01.CIR.92.11.3337 · DOI · Paper page
- 10.1002/syn.20547 · DOI
- 10.1073/pnas.161191698 · DOI · Paper page
- 10.1126/science.1470919 · DOI · Paper page
- 10.1016/S0165-6147(00)01712-0 · DOI · Paper page
- Ehrhart J, 2005, Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation, J Neuroinflammation, 12, 2
- 10.1016/S0300-9572(00)00321-X · DOI · Paper page
- 10.1016/S0014-2999(03)02074-0 · DOI
- 10.1016/S0014-2999(00)00653-1 · DOI · Paper page
- 10.1124/mol.62.6.1385 · DOI · Paper page
- 10.1177/1073858406296407 · DOI
- 10.1523/JNEUROSCI.5693-09.2010 · DOI · Paper page
- 10.1016/j.brainres.2006.03.011 · DOI
- 10.1016/j.molbrainres.2004.08.025 · DOI · Paper page
- 10.1046/j.1460-9568.2000.00217.x · DOI · Paper page
- 10.1016/S0306-4522(01)00287-1 · DOI · Paper page
- 10.1089/neu.1988.5.259 · DOI · Paper page
- 10.1016/j.lfs.2009.06.003 · DOI
- 10.1016/S1474-4422(08)70165-0 · DOI · Paper page
- 10.1523/JNEUROSCI.2347-05.2005 · DOI
- 10.1038/sj.embor.7400234 · DOI · Paper page
- Koch M, 2010, The cannabinoid WIN 55,212‐2‐mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav2.2 channels, Hippocampus
- 10.1016/S0165-0173(02)00157-1 · DOI · Paper page
- 10.1097/00019052-199412000-00007 · doi:10.1097/00019052-199412000-00007
- 10.1146/annurev.pharmtox.46.120604.141254 · DOI · Paper page
- 10.1186/1471-2202-11-44 · DOI · Paper page
- 10.1111/j.1471-4159.2005.03380.x · DOI · Paper page
- 10.1126/science.1088208 · DOI · Paper page
- 10.1016/S0014-2999(98)00777-8 · DOI
- 10.1073/pnas.0510676103 · DOI · Paper page
- 10.1523/JNEUROSCI.19-08-02987.1999 · DOI · Paper page
- 10.1016/S0074-7742(09)88012-4 · DOI
- 10.1111/j.1471-4159.2007.04642.x · DOI · Paper page
- 10.1096/fj.06-6164fje · DOI · Paper page
- 10.1074/jbc.M707960200 · DOI · Paper page
- 10.1038/35097089 · DOI · Paper page
- 10.1038/sj.jcbfm.9600047 · DOI · Paper page
- 10.1016/j.nbd.2005.11.004 · DOI · Paper page
- 10.1111/j.1369-1600.2008.00108.x · DOI · Paper page
- 10.1006/nbdi.1998.0221 · DOI · Paper page
- 10.1016/S0165-6147(97)01161-9 · DOI
- 10.1016/S0165-6147(00)01805-8 · DOI · Paper page
- 10.1523/JNEUROSCI.20-01-00051.2000 · DOI
- 10.1124/mol.54.3.459 · DOI · Paper page
- 10.1523/JNEUROSCI.16-14-04322.1996 · DOI · Paper page
- 10.1016/S0165-5728(96)00181-6 · DOI · Paper page
- 10.1016/S1359-6101(99)00008-8 · DOI · Paper page
- 10.1016/S0304-3940(99)00922-2 · DOI · Paper page
- 10.1155/2008/538141 · DOI
- 10.1002/glia.20983 · DOI · Paper page
- 10.1602/neurorx.1.1.71 · DOI
- 10.1096/fasebj.12.11.1035 · DOI · Paper page
- 10.1016/j.nurt.2008.10.036 · DOI · Paper page
- 10.1038/sj.jcbfm.9600447 · DOI · Paper page
- 10.1007/s11481-009-9148-4 · DOI
- 10.1016/j.nurt.2009.10.016 · DOI · Paper page
Cited by
Neuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention
Kumar, A., & Loane, D. J. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.008 · Cited by 710
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
Kendall, D. A., & Yudowski, G. A. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00294 · Cited by 359
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Lowe, H., Toyang, N., Steele, B., Bryant, J., & Ngwa, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179472 · Cited by 303
Naviaux, J. C., Wang, L., Li, K., Bright, A., Alaynick, W. A., Williams, K. R., Powell, S. B., & Naviaux, R. K. (2015) · Molecular Autism · doi:10.1186/2040-2392-6-1 · Cited by 285
The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptors
Bakas, T., van Nieuwenhuijzen, P. S., Devenish, S. O., McGregor, I. S., Arnold, J. C., & Chebib, M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.02.022 · Cited by 246
Metadata
- Authors
- Shohami, E., Cohen‐Yeshurun, A., Magid, L., Algali, M., & Mechoulam, R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-07-12
- Volume
- 163
- Issue
- 7
- Pages
- 1402-1410
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2142460361
- Cited by
- 168
- References
- 9
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endocannabinoids and traumatic brain injury. https://app.cochat.ai/papers/10.1111/j.1476-5381.2011.01343.x
- The paper
- Shohami, E., Cohen‐Yeshurun, A., Magid, L., Algali, M., & Mechoulam, R. (2011). Endocannabinoids and traumatic brain injury. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2011.01343.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.